Prostate cancer is expected to affect 29% of men in the U.S. in 2023. At advanced stages, therapeutic resistance is a major concern, underscoring the urgent need for alternative and targeted therapies.

With 210,000+ papers on prostate cancer in PubMed, target discovery could take months to years.

In this factsheet, we leveraged Causaly Cloud to extract only the most relevant targets from the entire volume of biomedical literature in seconds.

Key Takeaways:

• Target Landscape: Explore 700+ targets for prostate adenocarcinoma.
• Animal Models: Prioritize targets by animal studies, including mice and rats.
• Clinical Studies: Uncover ~140 targets from clinical trial publications.
• Top 25% Journals: Identify targets reported in the most reputable journals.
• 2023 Targets: Refine emerging targets by target-disease relationships.

Ready to Transform Your Research?

Tell us what you're working on, and we'll show you how Causaly can help you uncover hidden knowledge and accelerate your research.